Your browser doesn't support javascript.
loading
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults.
Sagawa, Zachary K; Goman, Cristina; Frevol, Aude; Blazevic, Azra; Tennant, Janice; Fisher, Bridget; Day, Tracey; Jackson, Stephen; Lemiale, Franck; Toussaint, Leon; Kalisz, Irene; Jiang, Joe; Ondrejcek, Lisa; Mohamath, Raodoh; Vergara, Julie; Lew, Alan; Beckmann, Anna Marie; Casper, Corey; Hoft, Daniel F; Fox, Christopher B.
Afiliación
  • Sagawa ZK; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Goman C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Frevol A; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Blazevic A; HDT Bio, Seattle, WA, USA.
  • Tennant J; Saint Louis University Center for Vaccine Development, St. Louis, MO, USA.
  • Fisher B; Saint Louis University Center for Vaccine Development, St. Louis, MO, USA.
  • Day T; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Jackson S; Bristol-Myers Squibb, Seattle, WA, USA.
  • Lemiale F; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Toussaint L; Janssen Vaccines, Leiden, The Netherlands.
  • Kalisz I; Advanced Bioscience Laboratories (ABL), Inc., Rockville, MD, USA.
  • Jiang J; Advanced Bioscience Laboratories (ABL), Inc., Rockville, MD, USA.
  • Ondrejcek L; Advanced Bioscience Laboratories (ABL), Inc., Rockville, MD, USA.
  • Mohamath R; Advanced Bioscience Laboratories (ABL), Inc., Rockville, MD, USA.
  • Vergara J; DF/Net Research, Inc., Seattle, WA, USA.
  • Lew A; DF/Net Research, Inc., Seattle, WA, USA.
  • Beckmann AM; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Casper C; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
  • Hoft DF; Universal Cells, Seattle, WA, USA.
  • Fox CB; Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.
Nat Commun ; 14(1): 1138, 2023 03 06.
Article en En | MEDLINE | ID: mdl-36878897

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de Subunidad / Vacunas contra la Tuberculosis / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas de Subunidad / Vacunas contra la Tuberculosis / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido